...
首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Comparative study of right portal vein ligation versus embolisation for induction of hypertrophy in two-stage hepatectomy for multiple bilateral colorectal liver metastases
【24h】

Comparative study of right portal vein ligation versus embolisation for induction of hypertrophy in two-stage hepatectomy for multiple bilateral colorectal liver metastases

机译:右门静脉结扎与栓塞诱导两阶段肝切除术治疗多发性双侧结直肠肝转移性肥大的比较研究

获取原文
获取原文并翻译 | 示例

摘要

Aim: In patients with two-stage hepatectomy (TSH) for multiple bilobar liver metastases from colorectal cancer, few clinical series compare functional remnant hypertrophy of the liver volume between right portal vein ligation (PVL) and embolisation (PVE). Our objective is to analyse the effectiveness of portal vein ligation to achieve hypertrophy of the functional remnant volume (FRV) of the liver and to compare the results with portal vein embolisation in a series of patients with multiple bilobar liver metastases from colorectal carcinoma. Patients and methods: Between September 2001 and September 2011 we performed a TSH in 41 patients with multiple bilobar colorectal liver metastases. A right PVL was performed in 23 patients with an insufficient FRV (three patients did not complete the second stage due to tumour progression and were excluded). We prospectively compare these results with the increased remnant volume obtained in 18 patients with right PVE. Results: The median FRV was higher in the patients with PVE, rising from 501 ml (range 309-703) to 636 ml (range 387-649), than those with PVL, rising from 510 ml (range 203-824) to 595 ml (range 313-1213) (p < 0.05). The median %FRVI was higher in the patients with PVE (median 40%; range 21-65%) than those with PVL (median 30%; range 21-60%) (p < 0.05). Conclusions: PVL and PVE were effective in all cases for obtaining hypertrophy of the FRV before major liver resection. Right PVE obtains better results and should be used where necessary to achieve a further increase in volume.
机译:目的:对于患有结直肠癌的多发性双叶肝转移的两期肝切除术(TSH)患者,很少有临床系列比较右门静脉结扎(PVL)和栓塞(PVE)之间的肝功能性残余肥大。我们的目标是分析门静脉结扎以实现肝脏功能残留量(FRV)肥大的有效性,并将结果与​​门静脉栓塞治疗在患有大肠癌的多发性双叶肝转移的一系列患者中进行比较。患者和方法:2001年9月至2011年9月,我们对41例多发性双叶结肠直肠癌肝转移患者进行了TSH。在23例FRV不足的患者中进行了正确的PVL(3例由于肿瘤进展而未完成第二阶段,因此被排除在外)。我们前瞻性地将这些结果与18例正确的PVE患者的残留量增加进行了比较。结果:PVE患者的中位FRV较高,从501 ml(范围从309-703)增加到636 ml(范围从387-649),比PVL患者从510 ml(范围从203-824)增加到595 ml(范围313-1213)(p <0.05)。 PVE患者(中位数40%;范围21-65%)高于PVL患者(中位数30%;范围21-60%)的中位%FRVI更高(p <0.05)。结论:PVL和PVE在所有病例中均有效,可在大肝切除之前获得FRV肥大。正确的PVE可获得更好的结果,应在必要时使用以实现更大的体积。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号